A Pilot Study for Instrument Development for Assessing Alchol Withdrawal Symptoms with Specific Sensitivity for Phenobarbital as a Detoxification Medication

2.50
Hdl Handle:
http://hdl.handle.net/10755/183048
Category:
Abstract
Type:
Presentation
Title:
A Pilot Study for Instrument Development for Assessing Alchol Withdrawal Symptoms with Specific Sensitivity for Phenobarbital as a Detoxification Medication
Author(s):
Blacher, Susan; Lindgren, Carolyn L.
Author Details:
Susan Blacher, RN, BSN, CARN, South Miami Hospital, Miami, FL, email: suzanB@baptisthealth.net; Carolyn L. Lindgren, PhD, RN
Abstract:
Purpose: The purpose of this pilot study is to develop an instrument that is objective in assessing alcohol withdrawal symptoms (AWS), sensitive to the use of Phenobarbital as the detoxification medication and assessment levels which are comparable to the broad categories of withdrawal symptoms in the current assessment tool.
Method: The procedure consists of comparing the Clinical Institute of Withdrawal Assessment for Alcohol (CIWA-AR) (Sullivan et al., 1989) and the Severity Assessment Scale (SAS) (Phillips et al., 2006) with the current method being used. The current method consists of assessing vital signs, patient self report of symptoms and nurse observation of symptoms using a mild, moderate or severe scale. The nurse participants are assessing a total of 20 patients using the three methods of assessment for each patient. Comparing the results among the two tools, the CIWA-AR and the SAS to the current method of assessment provides the basis for deciding which method provides the most sensitive description of the patient's symptoms as they are treated with Phenobarbital for withdrawal for AWS.
Findings: Preliminary findings indicate that ratings on the SAS were comparable to the "severe" category rating of the current method and patients received adequate medication for those "severe" rated symptoms. The CIWA-AR ratings were not comparable to the "severe" category of the current method and if the CIWA-AR ratings had been used for medication decisions, the patient would not have received adequate medication.
Discussion: CIWA-AR scale is considered the "gold standard" for assessing AWS symptoms and is often used when benzodiazepine is the detoxification medication being used. Based on the findings of this study, for patients receiving Phenobarbital, developing an objective, evidence-based and sensitive instrument similar to the SAS is indicated. The ratings on the SAS were comparable to the current broad categories and more detailed.

References:
Phillips, S., Haycock, C., & Boyle, D. (2006). Development of an alcohol withdrawal protocol. Clinical Nurse Specialist, 20(4), 190-198.

Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., & Sellers, E. M. (1989). Assessment of alcohol withdrawal: the revised clinical institute of withdrawal assessment for alcohol scale (CIWA-AR). British Journal of Addiction, 84(11), 1353-1357.
Repository Posting Date:
28-Oct-2011
Date of Publication:
28-Oct-2011
Conference Date:
2009
Conference Name:
6th Annual Florida Magnet Research Conference
Conference Host:
University of South Florida College of Nursing; Magnet Hospitals of Florida; Sigma Theta Tau International; Florida Organization of Nurse Executives
Conference Location:
Kissimmee, Florida
Description:
6th Annual Florida Magnet Research Conference � Theme: Research at the Point of Care. Held 12-13 February 2009 at Gaylord Palms Resort and Convention Center, Kissimmee, Florida, USA.
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleA Pilot Study for Instrument Development for Assessing Alchol Withdrawal Symptoms with Specific Sensitivity for Phenobarbital as a Detoxification Medicationen_GB
dc.contributor.authorBlacher, Susanen_US
dc.contributor.authorLindgren, Carolyn L.en_US
dc.author.detailsSusan Blacher, RN, BSN, CARN, South Miami Hospital, Miami, FL, email: suzanB@baptisthealth.net; Carolyn L. Lindgren, PhD, RNen_US
dc.identifier.urihttp://hdl.handle.net/10755/183048-
dc.description.abstractPurpose: The purpose of this pilot study is to develop an instrument that is objective in assessing alcohol withdrawal symptoms (AWS), sensitive to the use of Phenobarbital as the detoxification medication and assessment levels which are comparable to the broad categories of withdrawal symptoms in the current assessment tool.<br/>Method: The procedure consists of comparing the Clinical Institute of Withdrawal Assessment for Alcohol (CIWA-AR) (Sullivan et al., 1989) and the Severity Assessment Scale (SAS) (Phillips et al., 2006) with the current method being used. The current method consists of assessing vital signs, patient self report of symptoms and nurse observation of symptoms using a mild, moderate or severe scale. The nurse participants are assessing a total of 20 patients using the three methods of assessment for each patient. Comparing the results among the two tools, the CIWA-AR and the SAS to the current method of assessment provides the basis for deciding which method provides the most sensitive description of the patient's symptoms as they are treated with Phenobarbital for withdrawal for AWS. <br/>Findings: Preliminary findings indicate that ratings on the SAS were comparable to the &quot;severe&quot; category rating of the current method and patients received adequate medication for those &quot;severe&quot; rated symptoms. The CIWA-AR ratings were not comparable to the &quot;severe&quot; category of the current method and if the CIWA-AR ratings had been used for medication decisions, the patient would not have received adequate medication. <br/>Discussion: CIWA-AR scale is considered the &quot;gold standard&quot; for assessing AWS symptoms and is often used when benzodiazepine is the detoxification medication being used. Based on the findings of this study, for patients receiving Phenobarbital, developing an objective, evidence-based and sensitive instrument similar to the SAS is indicated. The ratings on the SAS were comparable to the current broad categories and more detailed. <br/><br/>References:<br/>Phillips, S., Haycock, C., &amp; Boyle, D. (2006). Development of an alcohol withdrawal protocol. Clinical Nurse Specialist, 20(4), 190-198. <br/><br/>Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., &amp; Sellers, E. M. (1989). Assessment of alcohol withdrawal: the revised clinical institute of withdrawal assessment for alcohol scale (CIWA-AR). British Journal of Addiction, 84(11), 1353-1357.en_GB
dc.date.available2011-10-28T16:12:21Z-
dc.date.issued2011-10-28en_GB
dc.date.accessioned2011-10-28T16:12:21Z-
dc.conference.date2009en_US
dc.conference.name6th Annual Florida Magnet Research Conferenceen_US
dc.conference.hostUniversity of South Florida College of Nursingen_US
dc.conference.hostMagnet Hospitals of Floridaen_US
dc.conference.hostSigma Theta Tau Internationalen_US
dc.conference.hostFlorida Organization of Nurse Executivesen_US
dc.conference.locationKissimmee, Floridaen_US
dc.description6th Annual Florida Magnet Research Conference � Theme: Research at the Point of Care. Held 12-13 February 2009 at Gaylord Palms Resort and Convention Center, Kissimmee, Florida, USA.en_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.